Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2025-12-25 @ 1:33 AM
NCT ID:
NCT00242294
Eligibility Criteria:
Main inclusion criteria:
* Patients with chronic obstructive pulmonary disease
* Current smoker or ex-smoker
* 30 to 80% of predicted FEV1 after inhalation of short acting beta stimulant
Main exclusion criteria:
* Patients with poorly controlled COPD
* Patients who need for long-term oxygen therapy
* Patients who have concurrent respiratory diseases such as asthma, diffuse panbronchiolitis, congenital sinobronchial syndrome, bronchiolitis obliterans, bronchiectasis, active tuberculosis, pneumoconiosis, pulmonary lymph vascular myoma, which are considered to affect the evaluation
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT00242294
Study Brief:
Protocol Section:
NCT00242294